Dr. Wade H Flowers Jr., PHARM.D., BCPS, CGP Pharmacist - Pharmacotherapy Medicare: Not Enrolled in Medicare Practice Location: 98 Poplar St, Blackfoot, ID 83221 Phone: 208-782-3770 Fax: 208-782-3709 |
Dr. Jason Michael Bailey, PHARM.D Pharmacist - Pharmacotherapy Medicare: Not Enrolled in Medicare Practice Location: 1441 Parkway Dr, Blackfoot, ID 83221 Phone: 208-785-2600 |
Dr. Joshua William Gehrke, PHARM.D Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 960 W Bridge St, Blackfoot, ID 83221 Phone: 208-412-4017 |
Dr. Chris C Lemon, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 700 East Alice, State Hospital South, Blackfoot, ID 83221 Phone: 208-785-8505 |
Dr. Cara Ann Liday, PHARM.D. Pharmacist - Pharmacotherapy Medicare: Not Enrolled in Medicare Practice Location: 98 Poplar St, Blackfoot, ID 83221 Phone: 208-785-3800 |
Dr. Donna Eileen Araki, PHARM D Pharmacist - Pharmacotherapy Medicare: Not Enrolled in Medicare Practice Location: 565 Jensen Grove Dr, Blackfoot, ID 83221 Phone: 208-785-0277 Fax: 208-785-0388 |
Mr. Guy William Andrews, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 565 Jensen Grove Dr, Blackfoot, ID 83221 Phone: 208-785-0277 Fax: 208-785-0388 |
Alan Wesley Bell, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 98 Poplar St, Mob Building, Blackfoot, ID 83221 Phone: 208-782-2990 Fax: 208-782-2931 |
News Archive
The end of the Affordable Care Act is within sight, House Majority Leader Eric Cantor says, outlining Republican plans to propose health care legislation later this year. "In my opinion, Obamacare is on borrowed time," the Virginia Republican said in an interview for Sunday on CBS's "Face the Nation."
MorphoSys AG and Boehringer Ingelheim announced today the signing of a biopharmaceutical manufacturing agreement for therapeutic antibodies. The agreement covers the process development and manufacturing of additional clinical material for MorphoSys's proprietary MOR208 program and other drug candidates. MOR208, a potent monoclonal anti-CD19 antibody, is in development for the treatment of chronic lymphocytic leukemia and potentially other B-cell malignancies. The program is currently being evaluated in a phase 1 clinical trial in the USA by MorphoSys's partner Xencor Inc.
A new report from the American Cancer Society and other world-leading health groups identifies gaps in research for 20 suspected carcinogens whose potential to cause cancer is as yet unresolved. The report is designed to prioritize agents for additional research, and to lead to well-planned epidemiologic or mechanistic studies leading to more definitive classification of these agents.
Craig Young, MD, was awarded the 2012 Founders Award at the 21th Annual Meeting of the American Medical Society for Sports Medicine, in Atlanta on April 24, 2012. The award is not given annually, but is bestowed when AMSSM leadership determines that someone exemplifies the best that a sports medicine physician can be and do.
› Verified 4 days ago